Firefly Neuroscience (AIFF) Other Accumulated Expenses (2015 - 2024)

Firefly Neuroscience has reported Other Accumulated Expenses for 10 years, with the latest figure at $230024.0 in Q2 2024.

• On a quarterly basis, Other Accumulated Expenses fell 55.07% year-over-year to $230024.0 in Q2 2024; TTM through Jun 2024 was $230024.0, a 55.07% decrease from a year earlier, with the FY2024 full-year figure at $230024.0, changed N/A from the prior year.
• Other Accumulated Expenses was $230024.0 for Q2 2024 at Firefly Neuroscience, up from $168658.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $816536.0 in Q1 2022, with the low at $7656.0 in Q2 2020.
• Average Other Accumulated Expenses over 5 years is $274381.1, with a median of $223566.0 recorded in 2023.
• The sharpest annual moves came in 2020 and 2022: Other Accumulated Expenses sank 86.3% in 2020, then jumped 10047.09% in 2022.
• Over 5 years, Other Accumulated Expenses stood at $54274.0 in 2020, then soared by 276.02% to $204080.0 in 2021, then jumped by 38.91% to $283497.0 in 2022, then retreated by 5.61% to $267604.0 in 2023, then retreated by 14.04% to $230024.0 in 2024.
• The last three Other Accumulated Expenses figures came in at $230024.0 (Q2 2024), $168658.0 (Q1 2024), and $267604.0 (Q4 2023), per Business Quant data.